Tower Research Capital (TRC)’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.1K | Buy |
8,004
+2,610
| +48% | +$11.1K | ﹤0.01% | 3306 |
|
|
2025
Q1 | $20.3K | Sell |
5,394
-17,320
| -76% | -$65.1K | ﹤0.01% | 2951 |
|
|
2024
Q4 | $132K | Buy |
22,714
+21,236
| +1,437% | +$124K | ﹤0.01% | 1991 |
|
|
2024
Q3 | $17.6K | Sell |
1,478
-7,722
| -84% | -$92.2K | ﹤0.01% | 3306 |
|
|
2024
Q2 | $99.5K | Buy |
9,200
+7,584
| +469% | +$82.1K | ﹤0.01% | 2583 |
|
|
2024
Q1 | $18.3K | Sell |
1,616
-8,906
| -85% | -$101K | ﹤0.01% | 3075 |
|
|
2023
Q4 | $148K | Buy |
10,522
+9,370
| +813% | +$131K | ﹤0.01% | 2332 |
|
|
2023
Q3 | $14.2K | Sell |
1,152
-20
| -2% | -$247 | ﹤0.01% | 3703 |
|
|
2023
Q2 | $10.6K | Sell |
1,172
-27,978
| -96% | -$253K | ﹤0.01% | 4075 |
|
|
2023
Q1 | $101K | Buy |
29,150
+19,358
| +198% | +$67.1K | ﹤0.01% | 1862 |
|
|
2022
Q4 | $24K | Buy |
9,792
+2,414
| +33% | +$5.92K | ﹤0.01% | 2966 |
|
|
2022
Q3 | $20K | Sell |
7,378
-748
| -9% | -$2.03K | ﹤0.01% | 3939 |
|
|
2022
Q2 | $33K | Buy |
8,126
+2,170
| +36% | +$8.81K | ﹤0.01% | 3280 |
|
|
2022
Q1 | $25K | Sell |
5,956
-915
| -13% | -$3.84K | ﹤0.01% | 3330 |
|
|
2021
Q4 | $64K | Buy |
6,871
+6,542
| +1,988% | +$60.9K | ﹤0.01% | 2571 |
|
|
2021
Q3 | $9K | Sell |
329
-900
| -73% | -$24.6K | ﹤0.01% | 4458 |
|
|
2021
Q2 | $34K | Buy |
1,229
+61
| +5% | +$1.69K | ﹤0.01% | 3353 |
|
|
2021
Q1 | $39K | Buy |
1,168
+598
| +105% | +$20K | ﹤0.01% | 3334 |
|
|
2020
Q4 | $27K | Buy |
+570
| New | +$27K | ﹤0.01% | 3663 |
|